Chapter

Genetic advances and health insurance

Lilia Filipova and Michael Hoy

in The Economics of New Health Technologies

Published in print May 2009 | ISBN: 9780199550685
Published online February 2010 | e-ISBN: 9780191720543 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780199550685.003.0008
 Genetic advances and health insurance

Show Summary Details

Preview

This chapter addresses the complex issue of the use of genetic advances by health insurance. Technical innovation in medical care in general generates a great deal of interest and controversy. Of particular interest is the role of insurance markets (or public insurance) in influencing the adoption of medical innovations. An additional important factor in the context of genetic advances, such as the development of new genetic tests, is the impact of regulations prohibiting insurers from using test results directly as relevant factors in the design and pricing of insurance contracts. Such regulations, of varying force, have been adopted throughout much of Europe. The chapter discusses how such regulations may affect the way that genetic advances affect the adoption of genetic tests and related health care strategies, and what impact this could have on both insurers and consumers.

Keywords: genetic advances; health insurance; medical care; medical innovations; insurance markets; genetic tests

Chapter.  12163 words. 

Subjects: Public Health and Epidemiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.